Liver

HepaShear™ testing accelerates the development of innovative new drug therapies and chemicals by determining the efficacy, safety and toxicity of new pharmaceutical compounds and industrial chemicals on an advanced human surrogate cell-culture model of the liver.

By applying human-derived liver blood flow patterns to a co-culture of primary human hepatocytes, sinusoidal endothelial cells and other liver cell-types, HepaShear™ testing recreates the structure and biology of the human liver.

The graphic below depicts several areas in drug discovery in which HepaShear™ testing will be deployed.